Cobalamin with a cyanide ligand at the central cobalt — must be dealkylated by cyanocobalamin reductase and reduced to cob(II)alamin before conversion to methylcobalamin (cytosol) or adenosylcobalamin (mitochondrion), the two active coenzyme forms. Oral absorption requires gastric intrinsic factor (IF) + ileal cubilin/amnionless uptake — saturable at ~1.5 mcg per dose; passive diffusion at ~1% above that.
Dietary Reference Intake
Vitamin B12 (cyano form). FDA Daily Value 2.4 mcg (21 CFR 101.9). No UL established.
Half-Life & Elimination Curve (PO: 6d)
Plasma (PO)t½ Decay (6d)
0×t½0h100%(0.267 µg/L)
1×t½6d50%(0.134 µg/L)
2×t½12d25%(0.0668 µg/L)
3×t½18d12.5%(0.0334 µg/L)
4×t½24d6.3%(0.0167 µg/L)
5×t½30d3.1%(0.00835 µg/L)
Elimination t½6d (PO)
Rate Constant (ke)0.00481 h⁻¹
Time to Peak (Tmax)14h
Est. Peak (Cmax)0.267 µg/L
Clearance (CL)0.202 L/h
97% Washout (5×t½)30d
Dosing Guidelines
Oral (PO): Typical 400 mcg (Range: 100–1000 mcg)
Sublingual (SL): Typical 400 mcg (Range: 100–1000 mcg)
Intramuscular (IM): Typical 400 mcg (Range: 100–1000 mcg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 3% · Volume of Distribution (Vd): 42 L · Absorption (ka): 0.3 h⁻¹ (t½ka ≈ 2.31h) [PMID 18709891]